Login
Inmode Ltd logo

Inmode Ltd

inmodemd.com

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. The company is headquartered in Yokneam, Northern (Hazafon) and currently employs 660 full-time employees. The company went IPO on 2019-08-08. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The firm have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.

Financial Snapshot

Revenue
TTM
$374.6M
Gross Margin
TTM
76.44%
Net Income
TTM
$77.51M
Current Assets
2026 Q2
$650.0M
Current Liabilities
2026 Q2
$79.44M
Current Ratio
2026 Q2
818.25%
Total Assets
2026 Q2
$720.3M
Total Liabilities
2026 Q2
$91.20M
Book Value
2026 Q2
629.1M
Cash
2026 Q2
$396.2M
P/E
TTM
11.09
Free Cash Flow
TTM
$82.53M

Stock Price

Loading...
Market Cap: $859.34 Million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support